To evaluate the potential for applying GMP-ready robotic systems to commercial-scale cell therapy manufacturing.

Collaboration with AstraZeneca will focus on scaling cell therapy manufacturing using GMP-ready end-to-end robotic ...

Multiply Labs' goal is to enable scalable, high-throughput manufacturing while maintaining rigorous quality and regulatory standards.

Researchers at Johns Hopkins, writing in the journal Cell, have found that a single brain stem cell can produce two stem cells just like itself. "If we can somehow cash in on this newly discovered ...